Vor Biopharma ( (VOR)) just unveiled an update. On December 31, 2025, Vor Biopharma Inc. entered into a separation agreement with its Chief Development Officer, Dr. Qing Zuraw, following her decision ...

If you read a book in 2025—just one book—you belong to an endangered species. Like honeybees and red wolves, the population of American readers, Lector americanus, has been declining for decades. The ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Vor Biopharma (VOR) rose ~17% on Tuesday after J.P. Morgan initiated its coverage with an Overweight recommendation and a Dec. 2026 price target of $43, citing a potential blockbuster status for the ...

The Lede Reporting and commentary on what you need to know today. This way of perceiving social reality—and particularly a person’s reading life—may seem inane, even deranged. But performative reading ...

Vor Biopharma Inc. (NASDAQ:VOR) on Tuesday priced an underwritten public offering of 10 million shares at $10.00 per share. The gross proceeds from the offering are expected to be $100 million. In ...

They say the holidays are the most wonderful time of the year, but around these parts, we know nothing tops the launch of the annual Popsugar Reading Challenge — our take on a virtual book club that ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Vor Biopharma ( (VOR)) has provided an ...

As an avid reader – and an author, too – I’m disheartened by frequent reports of a decline in reading for pleasure among young people. So when a friend recently asked me whether her daughter was ...

Reading for pleasure in the U.S. fell 40% over two decades, the study found. Fewer Americans are opening a book for fun each day, with reading for pleasure in the United States down 40% over the past ...

Sarah J. Maas, Freida McFadden and Emily Henry –– can these popular authors join forces and save the day against a dangerous decline in reading for enjoyment? Daily reading for pleasure has plummeted ...

Vor Bio has handed Dallan Murray a swift return to the workforce. Weeks after being let go by Sarepta Therapeutics, Murray has landed the chief commercial officer post in Vor’s new-look C-suite.